Refresh

Lincoln Pharmaceuticals Ltd. - Research Center

531633 LINCOLN Group (B) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19
Income

Operating income

510.31 472.08 413.06 376.09 353.04
Expenses

Material consumed

243.09 219.78 201.33 187.26 177.75

Manufacturing expenses

10.25 8.33 6.84 7.57 7.08

Personnel expenses

93.16 70.47 56.47 54.90 48.40

Selling expenses

1.16 0.06 0.05 0.19 0.28

Adminstrative expenses

73.48 77.96 67.02 66.80 59.21

Expenses capitalised

- - - - -

Cost of sales

421.14 376.61 331.71 316.72 292.71

Operating profit

89.17 95.47 81.35 59.37 60.33

Other recurring income

22.48 10.00 6.77 12.13 6.58

Adjusted PBDIT

111.65 105.47 88.12 71.50 66.90

Financial expenses

2.03 1.45 1.44 1.98 3.84

Depreciation

9.17 8.09 5.67 5.47 4.92

Other write offs

- - - - -

Adjusted PBT

100.46 95.93 81.01 64.05 58.14

Tax charges

27.56 26.57 20.61 14.48 11.51

Adjusted PAT

72.90 69.36 60.41 49.56 46.64

Non recurring items

-0.48 0.13 - - -

Other non cash adjustments

- - - - -

Reported net profit

72.42 69.49 60.41 49.56 46.64

Earnigs before appropriation

420.69 341.31 272.33 219.66 174.21

Equity dividend

3.00 3.00 - 4.77 2.38

Preference dividend

- - - - -

Dividend tax

- - - 1.23 0.62

Retained earnings

417.68 338.31 272.33 213.66 171.21
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com